首页 | 本学科首页   官方微博 | 高级检索  
     


erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines
Authors:Knowlden Janice M  Gee Julia M W  Barrow Denise  Robertson John F  Ellis Ian O  Nicholson Robert I  Hutcheson Iain R
Affiliation:(1) Welsh School of Pharmacy, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff, CF10 3NB, UK;(2) Professorial Unit of Surgery, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK;(3) Department of Histopathology, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK;(4) Department of Pharmacology, Radiology & Oncology, Cardiff University, School of Medicine, Heath Park, Cardiff, CF14 4XN, UK
Abstract:

Introduction  

Recently we reported that insulin receptor substrate 1 (IRS-1), classically an adaptor protein for the insulin-like growth factor type I receptor (IGF-IR), associates with the epidermal growth factor receptor in oestrogen receptor (ER)-positive (ER+) tamoxifen-resistant breast cancer cells. In this study, we examined whether IRS-1 also associates with another erbB receptor family member, erbB3, and what impact this might have on IGF-IR signalling in three ER+ breast cancer cell lines.
Keywords:breast cancer   erbB3   IRS-1   IGF-IR   resistance
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号